VEGFR3 gene structure, regulatory region, and sequence polymorphisms

FASEB Journal

Volumn 15, Issue 6, 2001, Pages 1028-1036

  Iljin, Kristiina ^a   Karkkainen, Marika J ^a   Lawrence, Elizabeth C ^b   Kimak, Mark A ^b   Uutela, Marko ^a   Taipale, Jussi ^a   Pajusola, Katri ^a   Alhonen, Leena ^c   Halmekytö, Maria ^c   Finegold, David N ^b   Ferrell, Robert E ^b   Alitalo, Kari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Endothelial cell; FLT4; Lymphangiogenesis; Promoter; Receptor tyrosine kinase

Indexed keywords

DNA; MESSENGER RNA; TYROSINE KINASE RECEPTOR; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; DNA FLANKING REGION; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; GENE EXPRESSION; GENE STRUCTURE; GENETIC POLYMORPHISM; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENIC MOUSE;

3T3 CELLS; ANIMALS; BASE SEQUENCE; CLONING, MOLECULAR; EMBRYO; ENDOTHELIUM; EXONS; HUMANS; INTRONS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; SEQUENCE HOMOLOGY, NUCLEIC ACID; VARIATION (GENETICS); VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

ANIMALIA; MUS MUSCULUS;

EID: 17744384709     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.00-0383com     Document Type: Article

References (52)

1. Mechanisms of angiogenesis
2. Regulation of angiogenesis via vascular endothelial growth factor receptors
3. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit
4. Nucleotide sequence and expression of a novel human receptor type tyrosine kinase gene (flt) closely related to the fms family
5. Identification of a new endothelial cell growth factor receptor tyrosine kinase
6. FLT4, a novel class III receptor tyrosine kinase in chromosome 5q33-qter
7. Chromosomal localization of FLT4, a novel receptor-type tyrosine kinase gene
8. Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors
9. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
10. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor
11. Vascular endothelial growth factor B, a novel growth factor for endothelial cells
12. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
13. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
14. A novel type of vascular endothelial growth factor: VEGF-E (NZ-7 VEGF) preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain
15. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2(KDR)but not VEGFR-1(Flt-1)receptor tyrosine kinases
16. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1
17. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
18. Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice
19. Failure of blood island formation and vasculogenesis in Flk-1-deficient mice
20. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3
21. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development
22. Expression of the fms-like tyrosine kinase FLT4 gene becomes restricted to endothelium of lymphatic vessels during development
23. On the origin of the abdominal lymphatics in mammals from the vena cava and renal veins
24. FLT4 receptor tyrosine kinase gene mapping to chromosome band 5q35 in relation to the t(2;5), t(5;6), and t(3;5) translocations
25. Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor Flt4
26. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
27. VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane
28. The mouse tie receptor tyrosine kinase gene: Expression during embryonic angiogenesis
29. Endothelial-specific gene expression directed by the tie gene promoter in vivo
30. Conditional transgene expression in endothelial cells
31. Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice
32. Identification of vascular endothelial growth factor (VEGF) receptor-2 (Flk-1) promoter/enhancer sequences sufficient for angioblast and endothelial cell-specific transcription in transgenic mice
33. Targeting gene expression to endothelial cells in transgenic mice using the human intercellular adhesion molecule 2 promoter
34. The human ICAM-2 promoter is endothelial cell-specific in vitro and in vivo and contains critical Sp1 and GATA binding sites
35. Human von Willebrand factor gene sequences target expression to a subpopulation of endothelial cells in transgenic mice
36. Characterization of the mouse von Willebrand factor promoter
37. Requirement of a GT box (Sp1 site) and two Ets binding sites for vascular endothelial cadherin gene transcription
38. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues
39. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer
40. FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines
41. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema
42. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase
43. Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts
44. Genomic organization of the flt-1 gene encoding for vascular endothelial growth factor (VEGF) receptor-1 suggests an intimate evolutionary relationship between the 7-Ig and the 5-Ig tyrosine kinase receptors
45. Genomic structure of the human KDR/flk-1 gene
46. Mechanism of transcriptional activation by Sp1: Evidence for coactivators
47. Role of Ets factors in the activity and endothelial cell specificity of the mouse Tie gene promoter
48. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4
49. Roles of ephrinB ligands and EphB receptors in cardiovascular development: Demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis
50. Cardiovascular gene therapy
51. A strategy for enhancing the transcriptional activity of weak cell type-specific promoters